Cargando…
Enhanced therapeutic efficacy of 5'deoxy-5-fluorouridine in 5-fluorouracil resistant head and neck tumours in relation to 5-fluorouracil metabolising enzymes.
Four human head and neck xenograft (HNX) tumour lines grown in nude mice and two murine colon carcinomas (Colon 26 and 38) were tested for their sensitivity to 5-fluorouracil (5-FU) and its prodrug 5'deoxy-5-fluorouridine (Doxifluridine, 5'd-FUR). 5-FU sensitivity at the maximum tolerated...
Autores principales: | Peters, G. J., Braakhuis, B. J., de Bruijn, E. A., Laurensse, E. J., van Walsum, M., Pinedo, H. M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1989
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2247094/ https://www.ncbi.nlm.nih.gov/pubmed/2522792 |
Ejemplares similares
-
Increased cytotoxicity and bystander effect of 5-fluorouracil and 5′-deoxy-5-fluorouridine in human colorectal cancer cells transfected with thymidine phosphorylase
por: Evrard, A, et al.
Publicado: (1999) -
Comparative Antitumor Activity of 5‐Fluorouracil and 5′‐Deoxy‐5‐fluorouridine in Combination with Radiation Therapy in Mice Bearing Colon 26 Adcnocarcinoma
por: Ishikawa, Tohru, et al.
Publicado: (1989) -
In vitro biochemical and in vivo biological studies of the uridine 'rescue' of 5-fluorouracil.
por: Peters, G. J., et al.
Publicado: (1988) -
Comparative Antitumor Activity and Intestinal Toxicity of 5′‐Deoxy‐5‐fluorouridine and Its Prodrug Trimethoxybenzoyl‐5′‐deoxy‐5‐fluorocytidine
por: Ninomiya, Yasuyuki, et al.
Publicado: (1990) -
Enhanced Antitumor Effect of 5′‐Deoxy‐5‐fluorouridine by Oral Administration with l‐Cysteine
por: Iigo, Masaaki, et al.
Publicado: (1989)